Amedeo's Top 20

Amedeo Smart

Independent Medical Education

30 June 2014

Multidisciplinary Journal Club

  1. Cooney G, Dwan K, Mead G.
    Exercise for depression.
    JAMA 2014;311:2432-3.

  1. Nyboe Andersen N, Pasternak B, Basit S, Andersson M, et al.
    Association between tumor necrosis factor-alpha antagonists and risk of cancer in patients with inflammatory bowel disease.
    JAMA 2014;311:2406-13.

  2. Fang J , Hao Q, Liu L, Li Y, et al.
    Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection.
    J Virol 2012;86:1010-20.

  3. Maartens G, Celum C, Lewin SR.
    HIV infection: epidemiology, pathogenesis, treatment, and prevention.
    Lancet 2014.

  4. Giovannoni G, Naismith RT.
    Natalizumab to fingolimod washout in patients at risk of PML: when good intentions yield bad outcomes.
    Neurology 2014;82:1196-7.

  1. Kansagara D, Papak J, Pasha AS, O'Neil M, et al.
    Screening for Hepatocellular Carcinoma in Chronic Liver Disease: A Systematic Review.
    Ann Intern Med 2014.

  2. Pd Med Collaborative Group.
    Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
    Lancet 2014.

  3. Parikh SA, Kay NE, Shanafelt TD.
    How we treat Richter syndrome.
    Blood 2014;123:1647-57.

  4. Criner GJ, Connett JE, Aaron SD, Albert RK, et al.
    Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
    N Engl J Med 2014;370:2201-10.

  5. Masclee GM, Valkhoff VE, Coloma PM, de Ridder M, et al.
    Risk for Upper Gastrointestinal Bleeding from Different Drug Combinations.
    Gastroenterology 2014.

  1. Fraser DM, Sullivan FM, Thompson AM, McCowan C, et al.
    Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study.
    Br J Cancer 2014.

  2. Oki Y, Noorani M, Lin P, Davis RE, et al.
    Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
    Br J Haematol 2014.

  3. Jokubaitis VG, Li V, Kalincik T, Izquierdo G, et al.
    Fingolimod after natalizumab and the risk of short-term relapse.
    Neurology 2014;82:1204-11.

  4. Mooiweer E, Fidder HH, Siersema PD, Laheij RJ, et al.
    Fecal Hemoglobin and Calprotectin Are Equally Effective in Identifying Patients with Inflammatory Bowel Disease with Active Endoscopic Inflammation.
    Inflamm Bowel Dis 2013.

  5. Marcus JL, Leyden WA, Chao CR, Chow FC, et al.
    HIV infection and incidence of ischemic stroke.
    AIDS 2014.

  1. van den Berg MW, Sloothaak DA, Dijkgraaf MG, van der Zaag ES, et al.
    Bridge-to-surgery stent placement versus emergency surgery for acute malignant colonic obstruction.
    Br J Surg 2014;101:867-73.

  2. Shulman LN, Berry DA, Cirrincione CT, Becker HP, et al.
    Comparison of Doxorubicin and Cyclophosphamide Versus Single-Agent Paclitaxel As Adjuvant Therapy for Breast Cancer in Women With 0 to 3 Positive Axillary Nodes: CALGB 40101 (Alliance).
    J Clin Oncol 2014.

  3. van der Veer A, Zaliova M, Mottadelli F, De Lorenzo P, et al.
    IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
    Blood 2014;123:1691-8.

  4. Lewitt PA, Mouradian MM.
    Predicting the development of levodopa-induced dyskinesias: a presynaptic mechanism?
    Neurology 2014;82:1574-5.

  5. Tomisti L, Rossi G, Bartalena L, Martino E, et al.
    Eur J Endocrinol 2014.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016